ASHLEY ROCK: Open Payments
NPI 1720854052 · JOLIET, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,721 in 72 payments from 30 companies in 2025. Trend: 2023 $0 · 2024 $1,256 · 2025 $1,721
Food & beverage: $1,551Education: $170
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $161 |
| Sumitomo Pharma America, Inc. | 11 | $152 |
| Regeneron Healthcare Solutions, Inc. | 5 | $141 |
| Procept Biorobotics Corporation | 1 | $133 |
| GlaxoSmithKline, LLC. | 7 | $132 |
| JAZZ PHARMACEUTICALS INC. | 2 | $129 |
| PROGENICS PHARMACEUTICALS, INC. | 4 | $99 |
| Janssen Biotech, Inc. | 3 | $77 |
| Endo USA, Inc. | 4 | $70 |
| Grifols USA, LLC | 3 | $59 |
Products named: DUPIXENT, GEMTESA, AQUABEAM ROBOTIC SYSTEM, XYWAV, PYLARIFY, FASENRA, ERLEADA, NUCALA.
Industry payments across IL — which companies pay providers there.
